Category: Diseases & Conditions
Australia Diseases & Conditions
-
2024-2029 Australia Anemia Diagnostic Testing Market Assessment - 2024 Supplier Shares and 2024-2029 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities
... any other published source, including: Supplier Sales and Shares by Segment and Test Volume and Sales Segment Forecasts by Test Supplier Strategies and SWOT Analysis Instrumentation Pipeline Emerging Technologies Opportunities for New Analyzers and Consumables ... Read More
-
Sleep Aids in Australia
... remains evident in Australia with many, particularly consumers aged 18-30 years, seeking help for anxiety, poor sleep quality and unhealthy sleep habits. In addition, the review period has seen surging inflation rates, higher interest rates, ... Read More
-
Australia Skin Treatment Market Report by Product Type (Chemical Peels, Microdermabrasion, Micro Needling Treatments, Traditional Beauty Treatments), Gender (Male, Female), Application (Acne, Atopic Dermatitis, Hyperpigmentation, Psoriasis, Deep Wrinkles, Freckles, Melasma, and Others), End-User (Clinics and Hospitals, Medical Spas and Salons, At-home), and Region 2024-2032
... Hospitals, Medical Spas and Salons, At-home), and Region 2024-2032 The Australia skin treatment market size reached US$ 352.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 484.5 Million by 2032, ... Read More
-
OTC Pain Medication Manufacturing in Australia - Industry Market Research Report
... other non-prescription pain-relief products. Rising confidence surrounding self-medication and the growing range of pain-relief products available are driving industry demand. Australia's ageing population is also aiding revenue growth, with OTC pain-relief products often used to ... Read More
-
2024 What's Next for Australia Diagnostics Market? - Supplier Shares and Strategies, 2023-2028 Volume and Sales Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2023 supplier shares, strategies, as well as 2023-2028 volume and sales forecasts for 500 ... Read More
-
2024 Australia Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers
... is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products for diagnosing genetic diseases, cancer, as well as forensic and paternity/HLA testing during the ... Read More
-
2024 Australia Molecular Diagnostics Market: 2023 Supplier Shares, Instrumentation Installed Base and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... supplier shares, the 2023-2028 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for ... Read More
-
2024 Australia Immunodiagnostics Market Database - 2023 Supplier Shares, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer, Clinical Chemistry, Endocrine, Immunoprotein and TDM Tests
... analysis not available from any other published source . This database from LeadingMarketResearch.com provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug ... Read More
-
2024 Australia Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Pipeline, Emerging Opportunities for Suppliers This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends ... Read More
-
Asia-Pacific Omega-3 Supplements Market, By Source (Fish Oil, Krill Oil, Algae Oil, Others), By Form (Tablets, Capsules, Soft Gels, Others), By Functionality (Cardiovascular Health, Brain, Nervous System & Mental Health, Eye Diseases, Diabetes, Others), By End User (Adults, Geriatric, Pregnant Women, Children, Infants), By Distribution Channel (Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Others), By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... End User (Adults, Geriatric, Pregnant Women, Children, Infants), By Distribution Channel (Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Others), By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, ... Read More
-
Australia And New Zealand Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... 2024, and is expected to reach USD 1.30 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029). Key Highlights A holistic study of the market studied has been carried out ... Read More
-
Australia and New Zealand Anemia in Pregnancy Market Report and Forecast 2024-2032
... and New Zealand anemia in pregnancy market size is anticipated to grow at a CAGR of 8.6% during the forecast period of 2024-2032, driven by the rising incidence of pregnancies across the region. Anemia in ... Read More
-
Australia and New Zealand Cutaneous T-cell Lymphoma Market Report and Forecast 2024-2032
... and New Zealand cutaneous T-cell lymphoma market size is anticipated to grow at a CAGR of 11.3% during the forecast period of 2024-2032, driven by the increasing prevalence of the condition and the development of ... Read More
-
Australia In Vitro Diagnostics Market Assessment By Product Type [Instruments, Reagents & Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Haemostasias, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Ophthalmology, Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... Application [Ophthalmology, Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F Australia in vitro diagnostics ... Read More
-
Asia Pacific Multiple Sclerosis Drugs Market, By Disease Type (Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS), Primary Progressive Multiple Sclerosis (PPMS), Severe Relapsing-Remitting Multiple Sclerosis (RES)); By Treatment (Preventive Therapies, Abortive Therapies/Treatment of Acute Exacerbations, Symptomatic Therapies); By Drug Type (Branded, Generic); By End User (Hospital & Clinics, Diagnostic Laboratories); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Competitive Landscape & Forecast, 2019–2029
... End User (Pharmaceutical & Biopharmaceutical Companies, Labs & Research Institutes, Healthcare Providers, Healthcare Payers); By Application (Drug Discovery & Development, Medical Diagnostics, Genomics & Precision Medicine, Radiotherapy, Risk Analysis); By Region (North America, Europe, Asia ... Read More
-
Health and Wellness in Australia
... a range of claims such as natural, organic, good source of minerals/vitamins, no sugar/no added sugar (particularly in beverages), low fat and high protein/fibre. Euromonitor International's Health and Wellness in Australia report tracks the developments ... Read More
-
Australia Speech Aid Devices Procedures Count by Segments and Forecast to 2030
... Aid Devices Procedures. The databook report provides procedure volumes within segments - Laryngeal Cancer procedures performed using Electrolarynx and Laryngeal Cancer procedures performed using Voice Prosthesis The Australia Speech Aid Devices Procedures report provides key ... Read More
-
Dairy Products and Alternatives in Australia
... for dairy products. According to the ABS Consumer Price Index, which measures the changes in the prices of goods in Australia, dairy products has seen the second highest increase in price amongst food products, second ... Read More
-
2023-2027 Australia Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
Australia & South Korea Diabetic Foot Ulcer Market Size and Forecasts (2020 - 2030), Country Share, Trends, and Growth Opportunity Analysis Coverage By: Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-Ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Mild, Moderate, and Severe), End User (Hospitals, Ambulatory Surgery Centers, and Home Care), and Country
... Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Mild, Moderate, and Severe), End User (Hospitals, Ambulatory Surgery Centers, and Home Care), and Country The Australia & South Korea diabetic foot ulcer market is projected ... Read More
-
Australia Blood Pressure Monitoring Market Overview, 2028
... public health. With a strong healthcare infrastructure, a health-conscious population, and an increasing frequency of chronic diseases, the demand for accurate and easily accessible blood pressure monitoring systems has skyrocketed. The aging population in Australia ... Read More
-
Australia Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 776 million by 2028, growing at a CAGR of 2.46% during the forecast period (2023-2028). The COVID-19 pandemic positively impacted the Australia Diabetes Care Devices Market growth. Patients with diabetes, infected with ... Read More
-
Australia And New Zealand Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion in 2023 to USD 1.27 billion by 2028, at a CAGR of 2.70% during the forecast period (2023-2028). Key Highlights A holistic study of the market studied has been carried out by incorporating various ... Read More
-
Australia Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 939.07 million by 2028, growing at a CAGR of 3.60% during the forecast period (2023-2028). The COVID-19 epidemic boosted the expansion of the Australia Diabetes Care Drugs Market. Diabetes patients infected with ... Read More
-
Australia Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 775.73 million by 2028, at a CAGR of 2.40% during the forecast period (2023-2028). During the COVID-19 pandemic, patients with diabetes were at higher risk for hospitalizations and complications due to hyper- or hypoglycemia, ... Read More
Research Assistance
